Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05338710
Other study ID # 22721
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 14, 2021
Est. completion date March 4, 2022

Study information

Verified date April 2022
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and relatedm dementias (ADRD). However, few interventions address the specific needs of care partners for those with frontotemporal degeneration (FTD). This study tests an intervention to support family caregivers for those with FTD.


Description:

Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and related dementias (ADRD). However, few interventions address the specific needs of care partners for those with frontotemporal degeneration (FTD), the most common form of dementia in adults under age 60. Caring for a family member with FTD can affect the psychological, social, and relational health of families. Care partners for those with the disease have higher levels of burden and depression, as well as more sleep disturbances and worse financial strain than care partners for those with ADRD. Psychoeducational interventions can alleviate some of the psychological symptoms associated with dementia caregiving, but few programs have been designed for care partners for persons with FTD. Further, many of the existing programs are inaccessible for families due to distance and cost. The STELLA (Support via TEchnology: Living and Learning with Advancing dementia) intervention is designed to teach ADRD care partners strategies for managing behavioral symptoms associated with dementia. STELLA uses videoconferencing to connect care partners, in their own homes, with experienced Guides (e.g., nurses). The Guides use cognitive behavioral techniques to assist care partners in identifying and implementing strategies to reduce distressing behavioral symptoms in the person with dementia. Our pilot work found that early versions of STELLA reduced the frequency of behavioral symptoms and care partner reactivity to them. In this study, the investigators will adapt STELLA to specifically address the needs of family care partners for persons with frontotemporal degeneration. Aim 1. Adapt STELLA to the needs of care partners for those with FTD 1. Gather FTD care partner feedback on STELLA and suggestions for tailoring STELLA for FTD 2. Adapt STELLA for FTD care partners based on end-user feedback Aim 2. Assess the feasibility, acceptability and STELLA-FTD with FTD care partners Aim 3. Assess the preliminary efficacy of STELLA-FTD on the primary outcomes: reducing the frequency of behavioral symptoms and care partner reactivity to the symptoms as measured on the Revised Memory and Behavior Problems Checklist (RMBPC).


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date March 4, 2022
Est. primary completion date March 4, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Care Partner for family member, close friend or kin with FTD, primary progressive aphasia, progressive supranuclear palsy or other frontotemporal degenerative dementia - Must speak English - Must be able to see and hear the videoconference-based interactions. Exclusion Criteria: - Family member does not care for someone with FTD conditions.

Study Design


Intervention

Other:
STELLA-FTD
Behavioral intervention for caregivers for those with FTD

Locations

Country Name City State
United States Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center Portland Oregon

Sponsors (2)

Lead Sponsor Collaborator
Oregon Health and Science University Association for Frontotemporal Degeneration

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Revised Memory and Behavior Problems Checklist (change is being assessed) Behavior Problems Checklist Assesses burden, stress: Higher scores on frequency indicate more upsetting behaviors, higher scores on reactivity indicate more caregiver burden Weeks 1 and 9 of study
Secondary Quality of life, care partners and care recipients (change is being assessed) Measures sense of quality of life for Care Partner; 13 items, higher scores suggest better quality of life Weeks 1 and 9 of study
Secondary Quality of life, care partners and care recipients (change is being assessed) Measures sense of quality of life for person with dementia (filled out by proxy caregiver): 13 items, higher scores suggest better quality of life Weeks 1 and 9 of study
Secondary Family Caregiver Self efficacy scale (change is being assessed) measures caregiver self efficacy for symptoms management and community support service use. Scale 10-100, higher scores indicating better sense of self-efficacy Weeks 1 and 9 of study
Secondary Center for Epidemiologic Studies Depression-10-item scale (change is being assessed); score is 0 (no depression) to 30 (severe depression). Depression in caregivers Weeks 1 and 9 of study
Secondary Marwit Meuser Caregiver Grief Index (change is being assessed) Caregiver grief; Scale 18-90, higher scores=worse grief Weeks 1 and 9 of study
Secondary Caregiver Guilt Questionnaire (change is being assessed) Caregiver guilt; score range 22-88, higher scores=worse guilt Weeks 1 and 9 of study
Secondary Contact survey How often do caregivers contact each other? 9 weeks after study start
Secondary Experience Survey Caregiver assessment of program 9 weeks after study start
Secondary Ten-item personality inventory Measures extra/introversion (provides information about introversion/extraversion, no "good" or "bad" scores Week 1 of study
See also
  Status Clinical Trial Phase
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT03272230 - Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System N/A
Active, not recruiting NCT03987295 - A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) Phase 2
Withdrawn NCT05497817 - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia N/A
Recruiting NCT04918251 - EEG and TMS-based Biomarkers of ALS, MS and FTD
Completed NCT01890343 - Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. Phase 2
Completed NCT01002300 - Oxytocin and Social Cognition in Frontotemporal Dementia N/A
Completed NCT00376051 - Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia Phase 4
Terminated NCT00159198 - Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Phase 1
Active, not recruiting NCT04516499 - Neurofilament Surveillance Project (NSP)
Recruiting NCT04747431 - A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN) Phase 1/Phase 2
Completed NCT03636204 - A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation Phase 1
Completed NCT01937013 - Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia Phase 2
Active, not recruiting NCT05075187 - Epidemiological Study in FRONtoTemporal Dementia
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A
Completed NCT02999282 - Rehabilitative Trial for the Rescue of Neurophysiological Parameters in Progranulin Deficient Subjects N/A
Completed NCT00594737 - Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia Phase 3
Recruiting NCT03225144 - Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Active, not recruiting NCT04993755 - A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD Phase 2
Recruiting NCT04114994 - Longitudinal Cognitive Assessment by BoCA